← Back to Clinical Trials
Recruiting NCT06104150

NCT06104150 Erythrocyte Transport of Lactate During Exercise (TELE Project)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06104150
Status Recruiting
Phase
Sponsor Technical University of Madrid
Condition Energy Metabolism
Study Type INTERVENTIONAL
Enrollment 84 participants
Start Date 2020-02-03
Primary Completion 2027-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
Intervallic submaximal exercise test

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 84 participants in total. It began in 2020-02-03 with a primary completion date of 2027-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goals of this clinical trial are: 1. to study lactate kinetic between plasma and erythrocytes during an intervallic exercise and its subsequent recovery, considering the blood pH, the genotype for the T1470A polymorphism of the SLC16A1 gene (rs1049434), and the amount of MCT1 in erythrocytes membrane; 2. to analyze the levels of MCT1 in the erythrocytes membrane according to training status and genotype for the T1470A polymorphism of SLC16A1 (rs1049434). For this, the project will have two phases: * In phase I, trained participants will perform one maximal incremental test and one intervallic submaximal test with a final active recovery. * Phase II, levels of the MCT1 protein in the erythrocyte membrane will be quantified from trained and sedentary participants.

Eligibility Criteria

Inclusion Criteria: * BMI between 18 and 25 kg/m2 * Not smoker * In the case of trained participants: training at least 5 hours/week, of which at least 3 must be aerobic/anaerobic endurance training. Presentation of a medical certificate attesting to their medical fitness (capability) to perform intense physical exercise. * In the case of sedentary participants, less than 1 day of training per week or less than 2 hours of structured exercise per week. Exclusion Criteria: * Presenting any pathology that could impede the correct performance of the tests, or could influence the main study variables. * In the case of the female sample, having irregular menstrual cycles, oligomenorrhea or amenorrhea.

Contact & Investigator

Central Contact

Rocío Cupeiro, PhD

✉ rocio.cupeiro@upm.es

📞 +34910677990

Principal Investigator

Rocío Cupeiro, PhD

PRINCIPAL INVESTIGATOR

Universidad Politecnica de Madrid

Frequently Asked Questions

Who can join the NCT06104150 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Energy Metabolism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06104150 currently recruiting?

Yes, NCT06104150 is actively recruiting participants. Contact the research team at rocio.cupeiro@upm.es for enrollment information.

Where is the NCT06104150 trial being conducted?

This trial is being conducted at Santander, Spain, Madrid, Spain.

Who is sponsoring the NCT06104150 clinical trial?

NCT06104150 is sponsored by Technical University of Madrid. The principal investigator is Rocío Cupeiro, PhD at Universidad Politecnica de Madrid. The trial plans to enroll 84 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology